Oncothyreon, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - 145 18
Cost of Revenue - - - -
Gross Profit - - 145 18
Operating Expenses
Research and Development 33,221 22,001 17,915 11,601
Sales, General and Admin. 8,002 6,498 6,929 7,901
Non-Recurring Items - - - -
Other - - - -
Operating Income (41,223) (28,499) (24,699) (19,484)
Income From Continuing Operations
Add'l Income/Expense Items 2,464 25,393 (17,326) 3,666
Earnings Before Interest and Tax (38,759) (3,106) (42,025) (15,818)
Interest Expense - 309 631 -
Earnings Before Tax (38,759) (3,415) (42,656) (15,818)
Income Tax - - - (200)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (38,759) (3,415) (42,656) (15,618)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (38,759) (3,415) (42,656) (15,618)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (38,759) (3,415) (42,656) (15,618)